147 related articles for article (PubMed ID: 38558085)
1. Chitosan-LeoA-DNA Nanoparticles Promoted the Efficacy of Novel LeoA-DNA Vaccination on Mice Against Helicobacter pylori.
Chaleshtori ZA; Rastegari AA; Nayeri H; Doosti A
Curr Microbiol; 2024 Apr; 81(5):125. PubMed ID: 38558085
[TBL] [Abstract][Full Text] [Related]
2. Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine.
Chehelgerdi M; Doosti A
J Nanobiotechnology; 2020 Apr; 18(1):63. PubMed ID: 32316990
[TBL] [Abstract][Full Text] [Related]
3. Novel csuC-DNA nanovaccine based on chitosan candidate vaccine against infection with Acinetobacter baumannii.
Hosseinnezhad-Lazarjani E; Doosti A; Sharifzadeh A
Vaccine; 2023 Mar; 41(13):2170-2183. PubMed ID: 36841724
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of DNA alginate nanovaccine induced immune-protection against Helicobacter pylori in Balb/C mice.
Kaveh-Samani A; Dalali S; Kaviani F; Piri-Gharaghie T; Doosti A
BMC Immunol; 2024 Feb; 25(1):11. PubMed ID: 38310250
[TBL] [Abstract][Full Text] [Related]
5. Activation of CD3
Xue LJ; Mao XB; Liu XB; Gao H; Chen YN; Dai TT; Shao SW; Chen HM; Chu XY
Cancer Biol Ther; 2019; 20(6):866-876. PubMed ID: 30786815
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
[TBL] [Abstract][Full Text] [Related]
7. Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine.
Gong Y; Tao L; Wang F; Liu W; Jing L; Liu D; Hu S; Xie Y; Zhou N
Mol Med Rep; 2015 Sep; 12(3):4123-4132. PubMed ID: 26095723
[TBL] [Abstract][Full Text] [Related]
8. Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice.
Li B; Chen L; Sun H; Yang W; Hu J; He Y; Wei S; Zhao Z; Zhang J; Li H; Zou Q; Wu C
Sci Rep; 2015 Oct; 5():14793. PubMed ID: 26434384
[TBL] [Abstract][Full Text] [Related]
9. A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
Du X; Xue J; Jiang M; Lin S; Huang Y; Deng K; Shu L; Xu H; Li Z; Yao J; Chen S; Shen Z; Feng G
Int J Nanomedicine; 2021; 16():1819-1836. PubMed ID: 33707942
[TBL] [Abstract][Full Text] [Related]
10. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
11. Potential Gastric Cancer Immunotherapy: Stimulating the Immune System with
Afkhamipour M; Kaviani F; Dalali S; Piri-Gharaghie T; Doosti A
Arch Immunol Ther Exp (Warsz); 2024 Jan; 72(1):. PubMed ID: 38346161
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of Helicobacter pylori outer inflammatory protein DNA vaccine efficacy by co-delivery of interleukin-2 and B subunit heat-labile toxin gene encoded plasmids.
Chen J; Lin L; Li N; She F
Microbiol Immunol; 2012 Feb; 56(2):85-92. PubMed ID: 22150716
[TBL] [Abstract][Full Text] [Related]
13. Oral immunization of BALB/c mice with recombinant Helicobacter pylori antigens and double mutant heat-labile toxin (dmLT) induces prophylactic protective immunity against H. pylori infection.
Zhong Y; Chen J; Liu Y; Zhang Y; Tang C; Wang X; Wang P; Chen W; Wei B; Liu M
Microb Pathog; 2020 Aug; 145():104229. PubMed ID: 32353579
[TBL] [Abstract][Full Text] [Related]
14. Oral immunization with recombinant Mycobacterium smegmatis expressing the outer membrane protein 26-kilodalton antigen confers prophylactic protection against Helicobacter pylori infection.
Lü L; Zeng HQ; Wang PL; Shen W; Xiang TX; Mei ZC
Clin Vaccine Immunol; 2011 Nov; 18(11):1957-61. PubMed ID: 21900527
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori outer inflammatory protein DNA vaccine-loaded bacterial ghost enhances immune protective efficacy in C57BL/6 mice.
Chen J; Li N; She F
Vaccine; 2014 Oct; 32(46):6054-60. PubMed ID: 25236588
[TBL] [Abstract][Full Text] [Related]
16. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.
Guo L; Liu K; Zhao W; Li X; Li T; Tang F; Zhang R; Wu W; Xi T
Appl Microbiol Biotechnol; 2013 Mar; 97(6):2367-78. PubMed ID: 23064457
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection.
Lü L; Cao HD; Zeng HQ; Wang PL; Wang LJ; Liu SN; Xiang TX
Vaccine; 2009 Feb; 27(7):972-8. PubMed ID: 19111590
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
[TBL] [Abstract][Full Text] [Related]
20. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model.
Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y
Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
